Identification of an unrelated HLA allele-matched hematopoietic stem cell (HSC) donor is a costly and time-consuming procedure. To improve search logistics, we have limited the search period to 6 months and have introduced a probability estimate of the chances of identifying a 10/10 HLA allele-matched donor. Probabilities were classified as high (495%), intermediate (50%) and low (o5% chance) based on allele and haplotype frequencies. By analyzing 350 consecutive searches between 2002 and 2005 (1719 donors tested), the probability estimates turned out to be correct for 96% (high), 88% (low) and 56% (intermediate) patients. For searches with a high probability of success, at least one of the 10 most frequent haplotypes in Caucasoids was found in 69% of the patients, but in only 11% of the patients with a low-probability estimate (Po0.00001). Survival probability at 3 years was significantly higher for HSCT patients classified with a high-probability estimate when compared to patients in the intermediate/low-probability groups (74 vs 51 and 54% respectively, P ¼ 0.01). The same difference in survival probabilities was observed when only 10/10 matched unrelated HSCT patients were analyzed. In the intermediate-/low-probability groups, patients with alternative (haploidentical, autologous) or mismatched unrelated donors had similar survival estimates. Probability prediction is therefore feasible in the search process for unrelated donors and can guide the therapeutic strategy.
Introduction
Allogeneic hematopoietic stem cell transplantation (HSCT) has increased in Europe at a rate of about 10% over recent years and even more so from unrelated donors.
1,2 For patients lacking an HLA-identical sibling donor a search for an unrelated HSC donor can be initiated through the Bone Marrow Donor Worldwide (BMDW registry). In 2005, 41% of the allografts were performed with HSC from an unrelated donor. 2 Despite the impressive increase in the number of HLA-typed volunteer donors worldwide, a significant percentage of patients will still not be transplanted. This essentially results from a lack of available donor(s) in BMDW, from unacceptable HLAallele mismatches detected upon confirmatory typing, or from patient deterioration during searches. 3 Allele compatibility for the HLA-A/B/C/DRB1/B3/B5/ DQB1 loci, defined as a 10/10 match, is a standard requested by many transplant centers. Since few of the recruited donors in BMDW are typed at this level of resolution and for all HLA loci, confirmatory typing of selected donors requires comprehensive DNA-based typing methods to determine the overall compatibility level. 4, 5 In the absence of a 10/10 matched donor, varying degrees of allele mismatches may be accepted, depending on the clinical context and local guidelines. Histocompatibility testing for the identification of a matched unrelated stem cell donor is therefore a costly and time-consuming procedure. 6 Waiting in vain for an ideal donor may delay alternative donor transplants, for example, haploidentical HSCT or non-transplant strategies. Therefore, a more precise estimate at the initiation of the search of the probability of identifying a compatible donor could possibly improve the therapeutic strategy. Indeed, in defined clinical situations, depending essentially on the risk of the underlying disease, an early transplant with a partially incompatible donor might be preferable to a prolonged search resulting in late transplantation, 7, 8 rapid conventional therapy might be preferable to waiting in others.
Previous studies have shown the relevance of common ABDR haplotypes to the probability of identifying a matched donor. 5, 9, 10 However, high-resolution typing of common ABDR haplotypes disclosed further allelic diversity and multiple bilocus associations (B-C, DR-DQ), thereby increasing the difficulties of the searches. As an example, the A2-B44-DR11 haplotype may comprise any of the three following five-loci combinations: A*0201-B*4402-Cw*0501-DRB1*1101-DQB1*0301, A*0201-B*4402-Cw*0501-DRB1*1104-DQB1*0301 and A*0201-B*4402-Cw*0704-DRB1*1101-DQB1*0301.
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An additional difficulty with unrelated donors resides in the fact that HLA-allelic combinations do not necessarily segregate on the same chromosome, as is obviously the case in patients with proven genotypes. This may influence compatibility assessments since allele frequency distribution within a given serotype can significantly differ from one ABDR haplotype to another. Search algorithms are currently being developed within the National Marrow Donor Program (NMDP) registry, based on the conversion of HLA assignments of patients and donors into search determinants, 5 and on allele and haplotype frequencies (HapLogic).
To improve search efficiency by the Swiss Blood Stem Cells (SBSC), the national registry in Switzerland and coordinator for unrelated donor searches, we changed the strategy in 2002 and introduced two new measures. We first limited the search duration to 6 months, and secondly, we introduced at the initiation of the search, a probability estimate of identifying a 10/10 matched donor, that is, compatible at the allele level for HLA-A/B/C/DRB1/B3/ B5/DQB1, categorized as high, intermediate and low. Here, we present an evaluation of this probability estimate and its implication on outcome.
Patients and methods
General procedure of unrelated donor searches All unrelated donor searches for patients to be transplanted in the four Swiss centers accredited for allogeneic HSCT are processed through SBSC. According to the guidelines of SBSC, an unrelated donor search is initiated after confirmatory typing of the patient by the national reference laboratory for histocompatibility (LNRH). Whenever available, the parents and sibling(s) are also typed to determine the genotypes. SBSC organizes the sending of blood samples to the LNRH for confirmatory typing, and final donor selection is carried out by the transplant center.
Probability assessment
Starting in 2002 transplant centers were provided with a probability estimate of identifying a HLA-A/B/C/DR/DQ 10/10 allele-matched donor. The probabilities were classified at the initiation of the search as high (that is, 495% chance to identify a 10/10 matched donor), low (that is, o5% chance), intermediate (that is, fair chance but possibly more donors will have to be screened as compared to the high category) and unknown. This estimate also included the number of ABDR-matched donors in BMDW, and specific characteristics of the patient's HLA type, that is, unusual B-Cw linkage or the presence of a rare variant in a particular serotype. The probability estimates were based on sound knowledge of HLA haplotype and allele frequencies in Caucasoid populations. [12] [13] [14] [15] [16] [17] [18] Published and local data sets with allele frequencies and multilocus haplotypes, such as described for the B44 serotype, 11 were useful for the estimations.
The presence of a rare allele (frequency o5% of a given serotype) or an uncommon B-Cw, DRB1-B3, DRB1-DQB1 associations qualified the patient in the low-probability group even if a frequent haplotype occurred on the second chromosome. Examples of rares alleles are A*0302, A*0205, A*0206, A*3004, B*1804, B*3502, B*4405, B*5102, DRB1*1303, DRB1*0402/03/05/07/08 and DRB1*1102/03. The presence of at least one frequent haplotype qualified the patient in the high-probability group unless a rare allele or uncommon B-Cw, DRB1-B3, DRB1-DQB1 association occurred on the second haplotype. Since most common haplotypes are shared between European and North American Caucasians, 10 the 10 most frequent haplotypes were as computed by Boucher et al. 19 based on the large data set of 4400 000 donors of the NMDP registry ( Table 1) . Nine of these 10 haplotypes are also present among the 10 most frequent haplotypes in the more limited data sets of the Swiss (www.bmdw.org) and German donor registries. 20 For B18, B27, B44 and B51 serotypes, B-Cw associations in the patient were evaluated with respect to data available in the BMDW registry and with published and local databases. [9] [10] [11] [12] [13] For example, a low-probability estimate would be assigned for a patient with the A2-B51-Cw*02-DR8 haplotype, since a very strong linkage with Cw*1402 on this haplotype has been observed (Tiercy J-M, unpublished data). When the two haplotypes of the patient did not belong to the most frequent ones, the search qualified as high when the most common alleles are identified by four-digit typing for each locus based on the frequency distribution described by Hurley et al. 21 The BMDW search program, which lists the potential donors that are allele mismatched for each locus, provides useful Table 1 The 10 most frequent haplotypes in Caucasoids based on the phenotypes computed by Boucher et al.
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Haplotype
Rank in the NMDP registry (4400 000) 19 Rank in SBSC registry (419 000) Rank in German registry (413 000) information for the probability estimate. For some less common ABDR phenotypes, the International registry database was sometimes informative if searches were run by introducing such phenotypes together with the A1-B8-DR3 or A3-B7-DR15 haplotypes. The occurrence of p2 donors in BMDW usually correlated with a low-probability estimate.
The tentative scoring system applied to the patient's group with an intermediate-probability estimate was based on the following HLA parameters: rare allele (score À5), unusual B-C linkage (score À5), presence of B18, B27, B39, B44, B58, B*3502/03/08, DRB1*11, DRB1*13, DRB1*04, DRB1*07 (score À1), B51-Cw*15 (score À1), B51-Cw*14 (score À2) and B51-Cw*X (score À3). The presence of a frequent ABDR haplotype (Table 1 ) was scored as þ 5, and that of a common B-C linkage (for example, B7-Cw*0702, B13-Cw*0602 and B37-Cw*1203) as þ 1. Presence of p2 donors in BMDW was scored as -2 and of 4100 donors as þ 1.
Search procedure
A total of 412 evaluations were sent to the transplant physicians for searches initiated between January 2002 and December 2005. As a result of these 412 evaluations, 350 searches were initiated, leading to the confirmatory typing of 1719 potential donors (range 1-17, average 4.91 donors/ patient). Confirmatory typing comprises HLA-AB serology and DRB1 two-digit DNA typing as a first step, followed by four-digit typing for A/B/C/DRB1/DRB3/DRB5/DQB1 loci, usually starting with DRB1, then A/B/C/DQB1 loci, the order depending on the incompatibility risk. 4 A 10/10 matched donor is defined by full compatibility (four-digit typing) at the A/B/C/DRB1/DRB3/DRB5/DQB1 loci, that is, the second DRB locus is also taken into account in the DR-matching scheme. DRB4 typing was also performed but was not taken into account in the matching algorithm. The logistics of the searches are coordinated by SBSC on a national basis, and the national reference laboratory performs all HLA-typing tests.
Of a total of 412 forms that were filled in, 21 patients (5.1%) had no ABDR-split or broad identical donor in Bone Marrow Donor Worldwide (BMDW) at the start of the search (Table 2 ). Eight searches were without attributable probability. For 33 patients no search was eventually started or no donor could be analyzed by the laboratory, either because the BMDW registered donors were not available, or because deteriorated clinical status of the patient precluded a search. These 62 patients (Table 2) were therefore not included in the analysis.
Definition of successful/failed estimation The probability estimate was considered as correct when a 10/10 allele-matched donor was eventually identified for searches classified as having a high or intermediate probability of success. The probability estimate was considered as incorrect either when a 10/10 matched donor was identified for patients with a low probability, or when no 10/10 matched donor could be identified for patients classified in the high or intermediate category.
The probability estimates were classified independent of whether a HSCT was performed or not.
Statistics
For the accuracy of the probability estimate, positive and negative predictive values were calculated. The main outcome measure was overall survival in transplanted patients. Outcome of patients transplanted with matched or mismatched donors was assessed using the Kaplan-Meier estimator. Comparison was by the log-rank test.
Results
Overall evaluation
The 350 patients for whom at least one donor had been analyzed (confirmatory typing) were evaluated separately for each category. As shown in Figure 1 and Table 2 , the prediction turned out to be correct for 96% (69/72, high), 88% (127/144, low) and 56% (75/134, intermediate) of the patients. To determine positive and negative a Predicted probability estimate to find a 10/10 matched donor, as defined at the initiation of the search. b N patients assigned with the indicated probability (N patients with a concordant outcome of the search/N patients with a discordant outcome), that is out of 72 patients with a high-probability estimate, a 10/10 matched donor was eventually identified for 69 patients, whereas for three patients (see Table 3 ) no matched donor was found in the 6 months time frame of the search. predictive values, only patients in the category of high and low probability were considered. The overall positive predictive value was 96 (88-99)% (95% CI) and the overall negative predictive value was 88 (82-93)% (95% CI).
Searches with a high probability A high-probability estimate was most frequently correct, as a 10/10 matched donor was identified for 96% of the patients ( Figure 1, Table 2 ) within the 6-months time frame of the search. In this group, 69% of the patients had at least 1 of the 10 most frequent haplotypes in Caucasoids (Table 1) , as compared to 11% for searches with a lowprobability estimate (Po0.00001). The average number of ABDR-split antigen matched donors available in BMDW at the start of the search was 274 (range 3-2866), and the average number of tested donors was 3.8. There were only three patients, classified in the high-probability group, for whom no 10/10 matched donor could be identified. These data are detailed in Table 3 . Patient no. 1 had an unusual B*1501-Cw*0303 linkage. For patient no. 2 mismatches occurred either on B7/B27/DR11 alleles, on DR16 vs DR15 serotype, or on DQB1*05 allele, and for patient no. 3 the DR7-DQB1*0303 linkage turned out to be very rare on the A2-B14-DR7 haplotype.
Of the 69 patients (high-probability group) for whom a 10/10 compatible donor was identified, 50 (72.5%) were transplanted (Table 4) . Three patients without a 10/10 matched donor were transplanted with a 9/10 matched donor. As expected the number of transplants with alternative donors (mismatched related or autologous) was low (1/72, 1.4%) in this category.
Searches with a low probability Of 144 searches that were initiated for patients with a lowprobability estimate, an average of 4.9 donors/patient were analyzed. For 127 patients no 10/10 matched donor could be identified, as predicted at the start of the search, whereas a compatible donor was eventually found for 17 patients (11.8%) ( Table 2) , without testing more donors/patient, on average.
As shown in Table 5 , the highest rate of incompatibility occurred on HLA-DRB1 (49.6%) and HLA-C (46.5%) loci. HLA-DRB1 disparities occurred in the following serotypes by decreasing order of frequency: DR4 (12.6%), DR13 (11.8%), DR11 (7.9%), DR2 (7.9%), DR8 (3.9%) and DR14 (3.1%). HLA-C disparities were essentially due to different linkages on B18, B27 and B51 haplotypes, and to unusual B-Cw associations in the patient (Table 5) .
Of those 144 searches with a low-probability estimate, 42 (29.2%) patients were transplanted with HSC from an unrelated donor, with the following compatibilities: 10/10 (12 patients), 9/10 (23 patients), 8/10 (5 patients) and 7/10 (2 patients) ( Table 4) . Alternative donors were selected by the transplant center for 17 patients: 12 haploidentical donors and 5 HLA-identical siblings who were not considered as potential donors at the beginning of the search. For 11 patients an autologous transplant was performed ( Table 4 ). The number of transplants with alternative donors (haploidentical or autologous) was highest in this category (16%, 23/144).
Searches with an intermediate probability As expected, the category of searches with intermediate probability revealed a similar distribution of patients with Table 4 Distribution of HSCT in different HLA matching categories in the three search groups with, respectively, high-, intermediate-and lowprobability estimates High  72  50  3  ----1  -54  Intermediate  134  46  21  2  -2  4  6  -81  Low  144  12  23  5  2  -12  11  5  70 The light-and dark-gray areas comprise, respectively, mismatched unrelated (n ¼ 55) and haploidentical/autologous (n ¼ 33) HSCT in the categories intermediate/low (see Table 7 ). a Autologous HSCT. b HLA-identical sibling, not available or considered as potential donor at the beginning of the search. There was a slight difference in the average number of donors tested when compared to the successful searches: 5.9 donors/patient in the discordant group vs 5.3 donors/patient in the concordant group. As compared to searches of the low-probability group, a larger percentage of patients in this category (71/134, 53%) was transplanted with HSC from an unrelated donor (Table 4 ). The number of transplants with alternative donors (related, autologous) was 7.5% (10/134) in this category (Table 4) , that is, intermediate between that of the high-and low-probability categories.
We attempted to improve the predictive value of the searches with an intermediate probability by developing a simple positive/negative scoring system as described in the Patients and methods section. By applying this score on the 134 searches classified with an intermediate probability, a negative score was found in 78% of the discordant samples (that is, patients with no 10/10 matched donor found), but in only 36% of the concordant samples (that is, patients with a successful search).
We therefore retrospectively reassigned the 134 patients either to the low-probability category when a negative score was calculated, or to the high-probability category when patients had a score X0. The data showed a concordance rate of 63% for the patients to the assigned low-probability category (negative score), and 79.7% to the patients assigned to the high-probability category (score X0) (data not shown). Therefore, the scoring system contributes to improving the predictive value of searches otherwise classified as intermediate only with score X0.
Overall HLA-compatibility rates The data in Table 6 show that a 10/10 matched donor could be identified for 46% of the 350 patients of the study group. A 9/10, 8/10 and p7/10 mismatched donor was found for 25.2, 13.7 and 9.7% of the patients, respectively. For 5.4% Table 5 Allele mismatches identified in donors selected for 127 patients correctly assigned in the category with a low probability of identifying a 10/10 match of the patients, incomplete donor typing did not permit the final level of compatibility to be ascertained, that is, further HLA typing was stopped after identification of two mismatches when no more than one disparity would have been accepted by the transplant center.
Kaplan-Meier 3-year survival rates of transplanted patients Kaplan-Meier 3-year survival estimates of transplanted patients were calculated for each category (Table 7 ). For the group of patients in the category with a high-probability estimate, a 75% (714%) overall survival rate was observed, significantly higher than in patients in the intermediate and low categories (51713%, respectively 54712%, P ¼ 0.01). This most likely reflects the differences in the donor HLAmatching grades (Table 4) . 22 The HLA-matching effect is confirmed when HSCT with 10/10 matched unrelated donors are compared with 6-9/10 matched donors (62710 vs 46714%, P ¼ 0.022) in the entire cohort of transplanted patients. When comparing 10/10 vs 9/10 matched HSCT, a borderline significant decrease in survival was observed in patients transplanted with HSC from a 9/10 matched donor (62710 vs 50716%, P ¼ 0.055). Furthermore, when outcome of 10/10 matched unrelated HSCT patients was compared in the high vs intermediate/low categories, a significant difference in survival was observed (73714 vs 52714%, P ¼ 0.01), possibly resulting from the higher occurrence of conserved haplotypes in the category with a high-probability estimate. 23 Interestingly, a 62717% survival rate was calculated for the 33 transplants with an alternative donor (that is, mismatched related/autologous) from searches with intermediate and low-probability estimates. This is not significantly (P ¼ 0.18) different from the rates observed for 56 patients transplanted with HSC from 6 to 9/10 (44715%), or even 10/10 matched (52714%) unrelated donors in the same categories (Table 7) . Owing to the specific design of the study, clinical data on non-transplanted patients were not available.
Discussion
Since 2002 the unrelated donor search strategy in Switzerland has included a probability estimate of identifying a 10/10 matched donor within the 6 months time frame of the search procedure. This estimation was based on the patients HLA haplotypes (rare alleles, uncommon linkages and frequent haplotypes), on local data sets of preferential haplotypic associations, 11 on available information in the BMDW data file, as well as on local experience in unrelated donor searches for the past 15 years. 4 The present data confirm the feasibility and accuracy of such an approach through high positive and negative predictive value of this estimate compared to the search end result.
Of all 350 consecutive searches that led to the confirmatory typing of at least 1 potential donor, 21% were considered to be of a high-probability estimate and 41% of a low-probability estimate. The most precise estimation concerned 72 patients with a high likelihood to have a 10/ 10 matched donor, for whom the concordance rate reached 96%. For this category the transplant physician will have more flexibility in considering non-HLA criteria, or possibly HLA-DPB1 matching, for the final donor selection, and the identification of a back-up matched donor can be more readily undertaken. HSCT has been performed in 74% of these patients.
The second category with a high concordance rate (88%) between estimate and actual search result consists of 144 patients for whom a low probability of finding a 10/10 matched donor had been assigned because of rare alleles, uncommon B-Cw, DRB1-DRB3, DRB1-DQB1 associations, or because of very low number of ABDR-matched (low resolution, mainly serology) donors in the international Table 7 Kaplan-Meier 3-year survival For patients in the intermediate category, the probability estimate turned out to be less reliable. A more accurate estimation was achieved by introducing a positive/negative scoring system based on the characteristics of the patients' phenotypes and on the number of available donors in BMDW. On the basis of our current knowledge of haplotypic associations and allele frequencies, only a score X0 (essentially determined by a frequent haplotype, a common B-C linkage, and a high number of available donors in BMDW) would improve the predictive value. The negative points allocated to specific serotypes or alleles (that is, B27, DRB1*0401) are probably still too crude to allow a significant improvement in the prediction, because the current knowledge of extended haplotypes (four-digit level) is too limited. For example, the allele A*0205 was recently identified in a patient at the start of the search on the presumed (no genotype available) haplotype A*0205-B*5001-Cw*0602-DRB1*0801-DQB1*0402. Because of the low frequency of A*0205 this patient was not classified as having a high probability of success. It turned out that four out of five donors were compatible for A2 allele showing that the presumed A*0205-B50-DR8 haplotype exhibits strong linkage disequilibrium. In any case the discrimination between an intermediate and low probability at the start of the search should be helpful in deciding whether the likelihood is high enough to justify testing 45 donors to identify a 10/10 matched donor.
As expected, a powerful predictor of outcome of the search was the presence of a frequent haplotype, which was the case in almost 70% of the searches classified as having a high probability, but in only 11% of the searches with a low probability. This confirms a previous study describing strategies of searching optimal donors based on a comprehensive analysis of the most frequent five-loci haplotypes in Western European Caucasians. 10 Another strong predictive factor is the presence of a rare HLA allele or an uncommon bi-locus combination.
The overall compatibility assessment of the 350 patients revealed that a 10/10 matched donor could be identified for 46% of the patients for whom X1 donor was available in the BMDW registry. If 9/10 matched donors are considered as well, a total of 71.2% patients, mainly of Caucasoid origin, could benefit from an unrelated HSCT, provided there was at least one ABDR-low-resolution matched donor available in BMDW. A 9/10 matched donor could eventually be identified for 70%, and respectively 36% of the patients in the intermediate and low categories that did not have a 10/10 matched donor.
The evaluation of 350 consecutive unrelated donor searches shows that the probability of identifying a 10/10 matched donor is highly predictable. Such a step should be integrated early on in the donor search process to identify patients in whom a donor search is likely to be successful and patients in whom other strategies, for example, mismatched transplants, cord blood transplant, other treatment options should be evaluated. We would recommend that for patients with a high-probability estimate the search should be limited to donors that fulfill additional criteria, such as male donors for male patients or CMV-negative donors for CMVnegative patients. A low-probability estimate could guide the transplant physician to an alternative choice, for example, chemotherapy, or autologous, or cord blood or haploidentical HSCT. In the absence of 10/10 or 9/10 matched donors, the choice of cord blood transplant or haploidentical donor might depend on disease, disease stage, patient age, patient/donor KIR ligand status and experience of the transplant team with a particular technique.
When comparing survival rates of transplanted patients in the high vs low/intermediate categories, a significant difference was found. This reflects, in part, the higher rate of mismatched HSCT in the low/intermediate categories known to be associated with lower survival, 1, 22 and possibly earlier decision to transplant in the high-probability group. However, even when restricting the analysis to patients receiving a 10/10 matched transplant, outcome remains better in the high-probability group as compared to the intermediate and low-probability groups. Such a difference could possibly be accounted for by a higher compatibility for non-HLA determinants encoded in the MHC, as would be expected with an increased frequency of conserved haplotypes in the category with a high-probability estimate. 23 These findings deserve further analysis, which is beyond the scope of this study. Treatment strategy was not defined by SBSC and outcome data could be obtained only for patients who did eventually receive a transplant with HSC from an unrelated, or related donor, or an autologous transplant. Although a true comparison is not possible, a few observations can still be made.
When alternative donors were selected for searches with low/intermediate probability, the survival rate (62%) was comparable to that of the entire group of transplanted patients in these categories (51/54%) and to that of transplants with a mismatched (6-9/10) donor (44%, P ¼ NS) (Table 7) . Therefore, in the event that no suitably matched unrelated donor can be identified within the 6 months search period, a decision to transplant with an alternative donor (haploidentical/autologous) does lead to a mortality rate comparable to, if not lower than, that of mismatched unrelated HSCT. These data should, however, be taken with caution since obviously a number of non-HLA factors also impact upon outcome.
The results presented in this study argue in favor of HLA-DRB1/high, and HLA-C/intermediate resolution typing of new donors since these two loci exhibited the highest rate of mismatches. Because disparities mostly involved the most common variants of a given serotype (for example, DRB1*1301, 1302 for DR13), 21 the typing strategies at donor registration resolving these common alleles in separate allele groups would be sufficiently efficient for optimum donor selection. Typing ambiguities involving uncommon alleles are therefore not expected to impact significantly on the selection process, at least for Caucasoid patients. The present data do not address the issue on the role of HLA-C and HLA-DQ matching, whose need is somewhat disputed. 1, 22 In Switzerland, we have documented the importance of 10/10 allele matching. 24 In this setting, assessment of the probability of finding such a donor is feasible. It should be integrated into the donor search process early and be used for the therapeutic strategy.
